Plantpharm

Plantpharm

98% of vaccines are given with needles. But, we’re changing that!

Print
Security Type
Preferred Stock
Categories
Other
Location
Delavan, WI
Offering Date
January 31, 2019
Expected Close Date
April 03, 2019
Target Raise
$100.00K
Deal Notes

Share Price: $1.50

Pro Rata Right Threshold: $25,000

Valuation
$33,000,000

Company Description

PlantPharm BioMed, Ltd. is a Biotech/Biopharmaceutical company having developed over more than 20 years a proprietary Platform production technology that allows for the creation of oral vaccines and pharmaceuticals grown organically in plants.

Use of Proceeds

Intermediary Fee: 5%

Business Development: 30%

Facility & Equipment: 20%

R&D: 45%

Management Team / Advisory Board Bios

Robert Britt - Founder, Chairman, CEO

Dr. Richard Matner - President

Dr. Thomas German - Chief Science Officer

Deal Notes

Share Price: $1.50

Pro Rata Right Threshold: $25,000

Amount Raised : $0
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments